Daewoong Pharmaceutical Co.,Ltd

About Daewoong Pharmaceutical Co.,Ltd

Since its establishment in 1945, Daewoong Pharmaceutical has grown to become one of the top 5 pharmaceutical companies in Korea. With its strong and competent in-house R&D and qualified manufacturing facilities (cGMP), Daewoong provides a total healthcare solution to patients across the globe. We manufacture various products (ETC&OTC) including Biologic, Chemical, Medical Device, etc. 

Products: Finished Dosage Formulations (Biologic & Chemical), APIs, Antibiotics, Enzymes
Interests: In-licencing, Out-licensing, CDMO, Co-Development, Open Collaboration

  • KR
  • 2015
    On CPHI since
  • 1000 - 4999
Company types
Pharmaceutical company
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Meet us at

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023

Products from Daewoong Pharmaceutical Co.,Ltd (5)


    Product NABOTA

    Botulinum toxin type A

    Indication: Glabella Lines (Approved in KR, US, Canada, on-going registration in EU), 
    Post Stroke Upper Limb Spasticity (Approved in KR), 
    Crow's feet (Approved in KR), Blepharospasm (Approved in KR)

    - NabotaTM is the only 900kDa neurotoxi...
  • Crezet

    Product Crezet

    1) Indication :  Treatment of primary hypercholesterolemia or to decrease elevated fat level in blood (mixed hyperlipidemia) in adult patients 
    2) Composition : Ezetimibe, Rosuvastain calcium (strength: 10/20mg, 10/10mg,10/5mg)
    3) Dosage & Administration : Once a day with or without m...
  • Enavogliflozin (SGLT2i)

    Product Enavogliflozin (SGLT2i)

    Enavogliflozin is a best-in-class SGLT2 inhibitor for T2DM.

    Highlights of Enavogliflozin:
    * NDA filed, Accelerated Approval granted by MFDS, expected market approval within 2022 for T2DM
    * T2DM Phase III was completed in Korea as a stand-alone and as combinations with other anti...
  • Epodion

    Product Epodion

    2000, 3000, 4000, 10000IU / Pre-filled syringe Inj.

    rhEPO (recombinant human erythropoietin)

    Anemia in chronic renal failure

    - EpodionTM is PFS type of Erytrhopoietin - alpha (rhEPO) for improving the hemoglobin and hematocrit level ...
  • Eposis

    Product Eposis

    2000, 3000, 4000, 5000, 6000, 8000, 10000IU / Pre-filled syringe Inj.

    rhEPO (recombinant human erythropoietin)

    Anemia in chronic renal failure

    - EposisTM demonstrated significant improvement and safety for patients with anemia in Chronic Renal Failure (CRF).

Daewoong Pharmaceutical Co.,Ltd Resources (2)

  • News Daewoong Pharm’s COVID-19 cure enters Phase 2 trial in Mexico

    An investigator-initiated Phase 2 clinical trial of Daewoong Pharm’s COVID-19 drug candidate has been kicked off at several health centers in Mexico, including Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. The sponsor-investigator study will evaluate the efficacy and safety profile of Foistar Tab. (camostat mesylate) in 180 COVID-19 patients with mild to moderate ...